ReviewCureus2025
A Project-Management Governance Model for Strengthening Biosafety Oversight in High-Risk Biological Research Facilities Across the United States: A Narrative Review.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the United States, there are high-risk biological research facilities with complex and overlapping management structures in an attempt to combat accidental or intentional exposure to dangerous pathogens. Even with numerous regulatory mechanisms and institutions biosafety committees, the recent evaluation of biosafety management shows that there are still a lot of gaps in governance, accountability fragmentation and inconsistency in the enforcement of biosafety management practices. The process of enhancing these oversight mechanisms needs to be organized, which is based on uniting the operational, institutional, and federal duties and control under a common system of governance. This narrative review will suggest a project-management governance model that is more integrative to facilitate better oversight of biosafety in the case of high-risk biological research in the United States. The model aims at enhancing stakeholder coordination, accountability and transparency in biosafety management by implementing project-management concepts in biosafety governance. A focused literature search was undertaken to locate peer-reviewed articles, governmental documents, and policy brochures within the past five years (2020-2025) with the help of PubMed, Scopus, and Google Scholar being used. Literature covering the issue of biosafety oversight, biosecurity governance and project-management systems were captured. The data were compiled in terms on the theme in order to determine governance aspects that are flexible to manage biosafety. The proposed model was informed by comparison of key concepts in the Project Management Body of Knowledge (PMBOK), ISO 21500, and the rest of governance standards to existing biosafety and biosecurity standards. The review reported four consistent challenges associated with biosafety governance, including: (1) lack of inter-agency coordination; (2) weak institutional accountability; (3) failure to communicate risk and performance reports/monitoring; and (4) lack of standard projects-governance organization. Project-management principles, which include the stakeholder mapping, the risk registers, the performance measures and the governance boards, can be incorporated to reinforce decision making and accountability. The model suggested is based on the three levels of governance consisting of strategic, operational, and project layer of governance, and the initiative of keeping the feedback and performance loop cycles. The implementation of the bio-safety regulation with the help of the project-management governance framework is an organized way to integrate the policy implementation, improve the risk treatment, and promote ongoing improvement in the high-risk researches. Put differently, the implementation of this model can strengthen national resiliency in biosafety, facilitate inter-agency partnerships, and develop an organizational culture of accountability and safety in the field of biological research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.